The International Vaccine Institute (IVI) and Seoul National University signed an agreement to expand collaboration in research.

Under the agreement, the two organisations will promote mutual cooperation in vaccine research and development, including the exchange of academic information and data for the discovery of new vaccines, and conduct of joint symposia and academic events and joint research and collaborative projects.

SNU has been engaging in research and academic exchange collaborations (with various organisations) that are necessary to address vaccine inequity and prevent infectious diseases in the international community based on its excellent education and research capacity.

Dr Jerome Kim, Director General of IVI, said, “IVI has had the privilege of having its headquarters on the campus of Seoul National University, one of the most prestigious academic institutions in the world. This agreement will open a new horizon to further expand our partnerships and collaborations in vaccines and related fields to accelerate vaccine science and innovation and contribute to global health.”